Investigation of patients with unclassified bleeding disorder and abnormal thrombin generation for physiological coagulation inhibitors reveals multiple abnormalities and a subset of patients with increased tissue factor pathway inhibitor activity.
Stephen MacDonaldDanielle WhiteJon LangdownKate DownesWilliam ThomasPublished in: International journal of laboratory hematology (2020)
TFPI activity may be increased in a subset of UBD patients. Further research studies are warranted in UBD patients for coagulation inhibitor abnormalities.